Professional Media briefs: June 2012

Share this article:

Communication company DMD is tweeting a marketing term a day on its new Twitter feed. The feed,  @DMD_Digital, posts a mix of new and old terms. SoLoMo—the convergence of social, local and mobile—is one recent example. A DMD rep told MM&M they hope to have of 2,000 followers by the end of the year.

Elsevier is the new publisher of The American Journal of Geriatric Psychiatry. Lippincott Williams & Wilkins, a division of Wolters Kluwer, has published the monthly journal for seven years. A spokesperson for the journal told MM&M that five potential publishers were in the running. “Elsevier was chosen based on the belief that it was best for the long-term growth of the journal—especially in the international arena,” she said.

Springer has hit a milestone in its efforts to digitize: the company said more than 200,000 titles are now part of the iBookstore inventory. The Springer Handbook of Nanotechnology, Pattern Recognition and ­Machine Learning and the series Graduate Texts in Mathe­matics are among the ebook titles being offered. Springer says that it also plans to digitize its archives, which date back to the 19th century.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?